- call +1-201-465-4211
- email sales@mrinsights.biz
Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.
Scope of the Report:
This report studies the Musculoskeletal Disorders Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Musculoskeletal Disorders Therapeutics market by product type and applications/end industries.
MSDs mostly occur because of the over-exhaustion of weak muscles, ligaments, or tendons. Also, vigorous vocational activities can lead to musculoskeletal pain. Uncured MSDs can result in chronic disruption of the mundane and vocational tasks of the patient. Some of the major therapeutics to treat MSDs include corticosteroids, biologics, parathyroid hormone, selective estrogen receptor modulators, protein therapy, synthetic bone graft, demineralized bone matrix, composite grafts, and BMPS, orthobiologics.
The global Musculoskeletal Disorders Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Musculoskeletal Disorders Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Pfizer
AbbVie
Johnson & Johnson
Sanofi
Merck
Novartis
Eli Lilly
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
Amgen
Takeda Pharmaceutical
Daiichi Sankyo
LG Life Sciences
Astellas
Samsung Bioepis
Zosano Pharma
Taisho Pharmaceutical
3SBio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biologics
Small Molecules
Other
Market Segment by Applications, can be divided into
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Musculoskeletal Disorders Therapeutics Market Overview
1.1 Product Overview and Scope of Musculoskeletal Disorders Therapeutics
1.2 Classification of Musculoskeletal Disorders Therapeutics by Types
1.2.1 Global Musculoskeletal Disorders Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Types in 2017
1.2.3 Biologics
1.2.4 Small Molecules
1.2.5 Other
1.3 Global Musculoskeletal Disorders Therapeutics Market by Application
1.3.1 Global Musculoskeletal Disorders Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Osteoarthritis
1.3.3 Osteoporosis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.3.7 Other
1.4 Global Musculoskeletal Disorders Therapeutics Market by Regions
1.4.1 Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Musculoskeletal Disorders Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Musculoskeletal Disorders Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Musculoskeletal Disorders Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Musculoskeletal Disorders Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Musculoskeletal Disorders Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Musculoskeletal Disorders Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 F. Hoffmann-La Roche
2.10.1 Business Overview
2.10.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Amgen
2.11.1 Business Overview
2.11.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Amgen Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Takeda Pharmaceutical
2.12.1 Business Overview
2.12.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Takeda Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.13 Daiichi Sankyo
2.13.1 Business Overview
2.13.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Daiichi Sankyo Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.14 LG Life Sciences
2.14.1 Business Overview
2.14.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.15 Astellas
2.15.1 Business Overview
2.15.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Astellas Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.16 Samsung Bioepis
2.16.1 Business Overview
2.16.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.17 Zosano Pharma
2.17.1 Business Overview
2.17.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.18 Taisho Pharmaceutical
2.18.1 Business Overview
2.18.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.19 3SBio
2.19.1 Business Overview
2.19.2 Musculoskeletal Disorders Therapeutics Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 3SBio Musculoskeletal Disorders Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Musculoskeletal Disorders Therapeutics Market Competition, by Players
3.1 Global Musculoskeletal Disorders Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Musculoskeletal Disorders Therapeutics Players Market Share
3.2.2 Top 10 Musculoskeletal Disorders Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Musculoskeletal Disorders Therapeutics Market Size by Regions
4.1 Global Musculoskeletal Disorders Therapeutics Revenue and Market Share by Regions
4.2 North America Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Musculoskeletal Disorders Therapeutics Revenue by Countries
5.1 North America Musculoskeletal Disorders Therapeutics Revenue by Countries (2013-2018)
5.2 USA Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Musculoskeletal Disorders Therapeutics Revenue by Countries
6.1 Europe Musculoskeletal Disorders Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Countries
7.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue by Countries (2013-2018)
7.2 China Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Musculoskeletal Disorders Therapeutics Revenue by Countries
8.1 South America Musculoskeletal Disorders Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Musculoskeletal Disorders Therapeutics by Countries
9.1 Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Musculoskeletal Disorders Therapeutics Market Segment by Type
10.1 Global Musculoskeletal Disorders Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Musculoskeletal Disorders Therapeutics Market Forecast by Type (2018-2023)
10.3 Biologics Revenue Growth Rate (2013-2023)
10.4 Small Molecules Revenue Growth Rate (2013-2023)
10.5 Other Revenue Growth Rate (2013-2023)
11 Global Musculoskeletal Disorders Therapeutics Market Segment by Application
11.1 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Musculoskeletal Disorders Therapeutics Market Forecast by Application (2018-2023)
11.3 Osteoarthritis Revenue Growth (2013-2018)
11.4 Osteoporosis Revenue Growth (2013-2018)
11.5 Psoriatic Arthritis Revenue Growth (2013-2018)
11.6 Ankylosing Spondylitis Revenue Growth (2013-2018)
11.7 Fibromyalgia Revenue Growth (2013-2018)
11.8 Other Revenue Growth (2013-2018)
12 Global Musculoskeletal Disorders Therapeutics Market Size Forecast (2018-2023)
12.1 Global Musculoskeletal Disorders Therapeutics Market Size Forecast (2018-2023)
12.2 Global Musculoskeletal Disorders Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Musculoskeletal Disorders Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Musculoskeletal Disorders Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Musculoskeletal Disorders Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Musculoskeletal Disorders Therapeutics Picture
Table Product Specifications of Musculoskeletal Disorders Therapeutics
Table Global Musculoskeletal Disorders Therapeu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
